Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

SHA:688621 Revenue

Beijing Sun-Novo Pharmaceutical Research had revenue of 197.10M CNY in the quarter ending March 31, 2026, a decrease of -14.62%. This brings the company's revenue in the last twelve months to 1.19B, up 12.44% year-over-year. In the year 2025, Beijing Sun-Novo Pharmaceutical Research had annual revenue of 1.22B with 13.33% growth.

• Revenue (ttm): 1.19B
• Revenue Growth: +12.44%
• P/S Ratio: 6.11
• Revenue / Employee: 890.27K
• Employees: 1,335
• Market Cap: 7.26B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.22B	143.77M	13.33%
Dec 31, 2024	1.08B	146.35M	15.70%
Dec 31, 2023	932.12M	255.51M	37.76%
Dec 31, 2022	676.61M	182.96M	37.06%
Dec 31, 2021	493.65M	146.29M	42.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error